{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T11:22:12Z","timestamp":1706095332350},"reference-count":31,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":71,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiol Drug Saf"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1002\/pds.3813","type":"journal-article","created":{"date-parts":[[2015,6,22]],"date-time":"2015-06-22T10:48:30Z","timestamp":1434970110000},"page":"785-792","source":"Crossref","is-referenced-by-count":11,"title":["Pediatric post-marketing safety systems in North America: assessment of the current status"],"prefix":"10.1002","volume":"24","author":[{"given":"Ann W.","family":"McMahon","sequence":"first","affiliation":[{"name":"Office of Pediatric Therapeutics, Office of the Commissioner; US Food and Drug Administration; Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerold T.","family":"Wharton","sequence":"additional","affiliation":[{"name":"Office of Pediatric Therapeutics, Office of the Commissioner; US Food and Drug Administration; Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renan","family":"Bonnel","sequence":"additional","affiliation":[{"name":"Office of Pediatric Therapeutics, Office of the Commissioner; US Food and Drug Administration; Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"DeCelle","sequence":"additional","affiliation":[{"name":"Office of Pediatric Therapeutics, Office of the Commissioner; US Food and Drug Administration; Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberley","family":"Swank","sequence":"additional","affiliation":[{"name":"Office of Pharmacovigilance and Epidemiology; US Food and Drug Administration; Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Testoni","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute; Duke School of Medicine; Durham NC USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith U.","family":"Cope","sequence":"additional","affiliation":[{"name":"Office of Pediatric Therapeutics, Office of the Commissioner; US Food and Drug Administration; Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip Brian","family":"Smith","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute; Duke School of Medicine; Durham NC USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen","family":"Wu","sequence":"additional","affiliation":[{"name":"Office of Pharmacovigilance and Epidemiology; US Food and Drug Administration; Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Dianne","family":"Murphy","sequence":"additional","affiliation":[{"name":"Office of Pediatric Therapeutics, Office of the Commissioner; US Food and Drug Administration; Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,6,22]]},"reference":[{"issue":"5","key":"10.1002\/pds.3813-BIB0001|pds3813-cit-0001","doi-asserted-by":"crossref","first-page":"e1242","DOI":"10.1542\/peds.2010-3487","article-title":"Extrapolation of adult data and other data in pediatric drug-development programs","volume":"128","author":"Dunne","year":"2011","journal-title":"Pediatrics"},{"key":"10.1002\/pds.3813-BIB0002|pds3813-cit-0002","volume-title":"Challenges Evaluating the Safety of Pediatric Therapeutic Agents in Trials and Post-Marketing Studies","year":"2013","edition":"2"},{"issue":"8","key":"10.1002\/pds.3813-BIB0003|pds3813-cit-0003","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.2105\/AJPH.2007.124537","volume":"98","author":"Berlin","year":"2008","journal-title":"Am J Public Health"},{"key":"10.1002\/pds.3813-BIB0004|pds3813-cit-0004","first-page":"103","volume-title":"Pharmacoepidemiology","year":"2005","edition":"4"},{"key":"10.1002\/pds.3813-BIB0005|pds3813-cit-0005","unstructured":"http:\/\/www.fda.gov\/ScienceResearch\/SpecialTopics\/PediatricTherapeuticsResearch\/ucm189227.htm"},{"issue":"4","key":"10.1002\/pds.3813-BIB0006|pds3813-cit-0006","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/PTS.0000000000000055","article-title":"Automated adverse event detection collaborative: electronic adverse event identification, classification, and corrective actions across academic pediatric institutions","volume":"9","author":"Stockwell","year":"2013","journal-title":"J Patient Saf"},{"key":"10.1002\/pds.3813-BIB0007|pds3813-cit-0007","unstructured":"http:\/\/www.fda.gov\/downloads\/ScienceResearch\/SpecialTopics\/PediatricTherapeuticsResearch\/UCM421091.pdf"},{"key":"10.1002\/pds.3813-BIB0008|pds3813-cit-0008","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-0673","article-title":"For the comparative effectiveness research through collaborative electronic reporting (CER2) consortium. Comparative effectiveness research through a collaborative electronic reporting consortium","author":"Fiks","year":"2015","journal-title":"Pediatrics"},{"key":"10.1002\/pds.3813-BIB0009|pds3813-cit-0009","unstructured":"https:\/\/perf-data.hrsa.gov\/mchb\/DGISReports\/Abstract\/AbstractDetails.aspx?Source=TVIS&GrantNo=UA6MC15585&FY=2013"},{"key":"10.1002\/pds.3813-BIB0010|pds3813-cit-0010","unstructured":"http:\/\/childrensnational.org\/healthcare-providers\/tools-for-your-practice\/childrens-iq-network"},{"issue":"6","key":"10.1002\/pds.3813-BIB0011|pds3813-cit-0011","doi-asserted-by":"crossref","first-page":"e66182","DOI":"10.1371\/journal.pone.0066192","article-title":"Multi-institutional sharing of electronic health record data to assess childhood obesity","volume":"8","author":"Bailey","year":"2013","journal-title":"PLOS One"},{"issue":"6","key":"10.1002\/pds.3813-BIB0012|pds3813-cit-0012","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00383-014-3513-y","article-title":"Demographic disparities of children presenting with symptomatic Meckel's diverticulum in children's hospitals","volume":"30","author":"Alemayehu","year":"2014","journal-title":"Pediatr Surg Int"},{"key":"10.1002\/pds.3813-BIB0013|pds3813-cit-0013","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/PCC.0000000000000270","article-title":"Factors contributing to endobronchial intubation in neonates","volume":"16","author":"Pinheiro","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"10.1002\/pds.3813-BIB0014|pds3813-cit-0014","article-title":"Variability of criteria for pasteurized donor human milk use: a survey of U.S. Neonatal ICU medical directors","volume":"pii","author":"Hagadorn","year":"2014","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1002\/pds.3813-BIB0015|pds3813-cit-0015","unstructured":"http:\/\/www.cpnds.ubc.ca\/index.php@option=com_content&view=article&id=17&Itemid=25.html"},{"issue":"5","key":"10.1002\/pds.3813-BIB0016|pds3813-cit-0016","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/pds.615","article-title":"The role of databases in drug postmarketing surveillanne","volume":"10","author":"Rodriguez","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"10.1002\/pds.3813-BIB0017|pds3813-cit-0017","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1177\/193229681200600509","article-title":"Pediatric use of insulin pump technology: a retrospective study of adverse events in children ages 1-12 years","volume":"6","author":"Cope","year":"2012","journal-title":"J Diabetes Sci Technol"},{"key":"10.1002\/pds.3813-BIB0018|pds3813-cit-0018","unstructured":"Flack M Reed T Crowley J Gardner S Identifying, understanding, and communicating medical device use errors: observations from an FDA pilot program Advances in Patient Safety From Research to Implementation Advances in Patient Safety"},{"key":"10.1002\/pds.3813-BIB0019|pds3813-cit-0019","unstructured":"http:\/\/www.fda.gov\/Safety\/FDAsSentinelInitiative\/ucm2007250.htm"},{"key":"10.1002\/pds.3813-BIB0020|pds3813-cit-0020","unstructured":"Albert M McCaig LF Injury-related emergency department visits by children and adolescents: United States, 2009-2010 NCHS Data Brief"},{"issue":"1","key":"10.1002\/pds.3813-BIB0021|pds3813-cit-0021","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/phar.1153","article-title":"Analysis of benzonatate overdoses among adults and children from 1969-2010 by the United States Food and Drug Administration","volume":"33","author":"McLawhorn","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1002\/pds.3813-BIB0022|pds3813-cit-0022","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jped.2013.11.002","article-title":"Evaluation of national health-care related infection criteria for epidemiological surveillance in neonatology","volume":"90","author":"Ferreira","year":"2014","journal-title":"J Pediatr (Rio J)"},{"issue":"2","key":"10.1002\/pds.3813-BIB0023|pds3813-cit-0023","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/15563650.2013.878948","article-title":"2012 pediatric fatality review of the National Poison Database System","volume":"52","author":"Calello","year":"2014","journal-title":"Clin Toxicol (Phila)"},{"issue":"4","key":"10.1002\/pds.3813-BIB0024|pds3813-cit-0024","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00006454-200404000-00002","article-title":"Understanding vaccine safety information from the Vaccine Adverse Event Reporting System","volume":"23","author":"Varricchio","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1002\/pds.3813-BIB0025|pds3813-cit-0025","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1016\/j.vaccine.2014.07.073","article-title":"The vaccine safety datalink: successes and challenges monitoring vaccine safety","volume":"32","author":"McNeil","year":"2014","journal-title":"Vaccine"},{"key":"10.1002\/pds.3813-BIB0026|pds3813-cit-0026","first-page":"994","article-title":"Federating clinical data from six pediatric hospitals: process and initial results from the PHIS+ Consortium","volume":"2011","author":"Narus","year":"2011","journal-title":"AMIA Annu Symp Proc"},{"issue":"4","key":"10.1002\/pds.3813-BIB0027|pds3813-cit-0027","doi-asserted-by":"crossref","first-page":"e861","DOI":"10.1542\/peds.2008-1011","article-title":"An intervention to decrease narcotic-related adverse drug events in children's hospitals","volume":"122","author":"Sharek","year":"2008","journal-title":"Pediatrics"},{"issue":"3","key":"10.1002\/pds.3813-BIB0028|pds3813-cit-0028","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/archpedi.161.3.282","article-title":"Off-label drug use in hospitalized children","volume":"161","author":"Shah","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"2","key":"10.1002\/pds.3813-BIB0029|pds3813-cit-0029","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MPG.0b013e31802f6424","article-title":"Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease","volume":"44","author":"Mackey","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1002\/pds.3813-BIB0030|pds3813-cit-0030","unstructured":"Wu Eileen Personal communication 2014"},{"issue":"7","key":"10.1002\/pds.3813-BIB0031|pds3813-cit-0031","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/INF.0b013e31828be70b","article-title":"Adverse events associated with meropenem versus imipenem\/cilastatin therapy in a large retrospective cohort of hospitalized infants","volume":"32","author":"Hornik","year":"2013","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3813","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pds.3813","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T23:32:27Z","timestamp":1625355147000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.3813"}},"subtitle":["Pediatric Post-Marketing Safety Systems"],"short-title":[],"issued":{"date-parts":[[2015,6,22]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"URL":"https:\/\/doi.org\/10.1002\/pds.3813","archive":["Portico"],"relation":{},"ISSN":["1053-8569"],"issn-type":[{"value":"1053-8569","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6,22]]}}}